Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective.

Del Prete A, Duran Jimenez B, Black A

Open source

DOI
10.1177/10430342261473434
Published
2026 Aug 12
Container
Human gene therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10430342261473434,
  title = {Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective.},
  author = {Del Prete A and Duran Jimenez B and Black A},
  year = {2026},
  journal = {Human gene therapy},
  doi = {10.1177/10430342261473434},
  url = {https://doi.org/10.1177/10430342261473434}
}

RIS

TY  - JOUR
TI  - Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective.
AU  - Del Prete A
AU  - Duran Jimenez B
AU  - Black A
PY  - 2026
JO  - Human gene therapy
DO  - 10.1177/10430342261473434
UR  - https://doi.org/10.1177/10430342261473434
ER  - 

APA

A, D. P., B, D. J., & A, B. (2026). Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective.. Human gene therapy. https://doi.org/10.1177/10430342261473434

Source records